石四药集团(02005.HK)获执行董事兼主席兼行政总裁曲继广增持44万股

Core Viewpoint - The executive director, chairman, and CEO of China Pharmaceutical (石四药集团) increased his shareholding by acquiring 440,000 shares at an average price of HKD 3.2797 per share, totaling approximately HKD 1.4431 million, resulting in a slight increase in his ownership percentage from 39.70% to 39.72% [1][2]. Group 1 - The executive director and CEO, 曲继广, purchased 440,000 shares of China Pharmaceutical on September 8, 2025 [1][3]. - The total investment for the share purchase was about HKD 1.4431 million [1]. - Following the acquisition, 曲继广's total shareholding reached 1,172,182,000 shares [1][2].